How much cash does TuHURA Biosciences, Inc. generate?

TuHURA Biosciences, Inc. (HURA) generated -$27.3M in operating cash flow over the trailing twelve months.

What is TuHURA Biosciences, Inc.'s free cash flow?

After $82.3K of capital expenditures, TuHURA Biosciences, Inc.'s free cash flow was -$27.4M over the trailing twelve months, down 98.3% year over year.

Where does TuHURA Biosciences, Inc.'s cash flow data come from?

Every line is extracted from TuHURA Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

TuHURA Biosciences, Inc. HURA Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23
Net income	-$30.05M-75.6%	-$17.11M+41.6%	-$29.32M-29.4%
Depreciation and amortization	$71.27K-29.4%	$100.88K—	——
Stock-based compensation	$6.42M+292%	$1.64M—	——
Change in accounts payable	-$3.91M—	——	——
Change in other assets	-$155K—	——	——
Debt issuance costs and discount amortization	$481.42K-62.3%	$1.28M+24,850%	$5.12K—
Change in other current assets	-$457.52K-198%	$464.94K+23,205%	$2K—
Net cash from operating activities	-$27.63M-140%	-$11.49M—	——
Capital expenditures	$76.08K+31.4%	$57.91K—	——
Acquisitions, net of cash acquired	——	——	——
Net cash from investing activities	-$1.34M+77.9%	-$6.05M—	——
Repayments of debt	——	$28.57M+964%	$2.69M—
Proceeds from issuance of common stock	——	$5M—	——
Payments for finance leases	——	——	——
Payment of debt issuance costs	——	$1.12M—	——
Dividends paid on preferred stock	$8.36K—	——	——
Net cash from financing activities	$19.93M-33.1%	$29.77M—	——
Net increase (decrease) in cash	——	$8.99M—	——
Interest paid	——	——	——
Increase (Decrease) in Other Current Assets	-$457.52K-198%	$464.94K+23,205%	$2K—
Payments To Acquire Business Two Net Of Cash Acquired	——	——	——
Finance Lease, Principal Payments	——	——	——
Payments of Ordinary Dividends, Preferred Stock and Preference Stock	$8.36K—	——	——
Proceeds From Warrant Exercises	——	——	——
Repayments Of Assumed Debt	$434K—	——	——
Change In Fair Value Of Holdback Shares	-$1.59M—	——	——
Contingent Value Rights Associated With Kintara Merger	——	$5.13M—	——
Deferred Offering Costs Not Yet Paid	$463.9K—	——	——
Due From Stockholders Not Yet Received For Warrant Exercises	——	——	——
Merger Transaction Costs Not Yet Paid	——	$500K—	——
Net Liabilities Assumed In Reverse Recapitalization Not Yet Paid	——	$550K—	——
Payment Of Net Liabilities Assumed In Reverse Recapitalization	——	$796.91K—	——
Payment Of Placement Agent Fees And Offering Costs	——	——	——
Payments Of Merger Related Costs Financing Activities	——	$3.63M—	——
Payments To Severance Promissory Notes	$394.71K—	——	——
Proceeds From Notes Payable	$3M—	——	——
Shares Issued For Payment Of Bridge Note	$1.75M—	——	——
Shares Issued For Placement Agent Fees	——	$443.56K—	——
Shares Issued Upon Settlement Of Convertible Notes	——	$27.74M—	——
Warrants Issued Recorded As A Debt Discount	$301.42K-95.4%	$6.52M—	——
Warrants Issued To Financial Advisor	——	$1.64M—	——
Free cash flow	-$27.71M-87.4%	-$14.79M—	——
Free cash flow	-$27.71M-87.4%	-$14.79M—	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does TuHURA Biosciences, Inc. generate?: TuHURA Biosciences, Inc. (HURA) generated -$27.3M in operating cash flow over the trailing twelve months.
What is TuHURA Biosciences, Inc.'s free cash flow?: After $82.3K of capital expenditures, TuHURA Biosciences, Inc.'s free cash flow was -$27.4M over the trailing twelve months, down 98.3% year over year.
Where does TuHURA Biosciences, Inc.'s cash flow data come from?: Every line is extracted from TuHURA Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.